1. Home
  2. SCD vs MYGN Comparison

SCD vs MYGN Comparison

Compare SCD & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LMP Capital and Income Fund Inc.

SCD

LMP Capital and Income Fund Inc.

N/A

Current Price

$14.67

Market Cap

357.8M

Sector

Finance

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.53

Market Cap

372.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCD
MYGN
Founded
2003
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.8M
372.1M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SCD
MYGN
Price
$14.67
$5.53
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
★ $5.90
AVG Volume (30 Days)
59.7K
★ 2.9M
Earning Date
01-01-0001
11-04-2026
Dividend Yield
★ 9.63%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $771,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$13.79
$2.74
52 Week High
$16.18
$8.09

Technical Indicators

Market Signals
Indicator
SCD
MYGN
Relative Strength Index (RSI) 40.12 50.83
Support Level N/A $4.19
Resistance Level $15.53 $6.34
Average True Range (ATR) 0.33 0.34
MACD -0.03 -0.13
Stochastic Oscillator 0.00 8.24

Price Performance

Historical Comparison
SCD
MYGN

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: